256 filings
8-K
JAGX
Jaguar Health Inc
9 Apr 24
Jaguar Health Reports Approval of All Proposals at April 2024 Special Meeting of Stockholders
5:26pm
8-K
JAGX
Jaguar Health Inc
21 Mar 24
Agreement terms to include payment of double-digit royalties to Jaguar on all Crofelemer products sold in the licensed territory
4:30pm
8-K
JAGX
Jaguar Health Inc
8 Mar 24
Unregistered Sales of Equity Securities
5:00pm
8-K
JAGX
Jaguar Health Inc
1 Mar 24
Entry into a Material Definitive Agreement
5:30pm
8-K
JAGX
Jaguar Health Inc
16 Feb 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:13pm
8-K
lrpf5dbwr91
1 Dec 23
Entry into a Material Definitive Agreement
5:25pm
8-K
e4l w5r1q
8 Nov 23
Jaguar Health Receives Additional 180-day Grace Period to Regain Compliance with Nasdaq’s Bid Price Rule
5:03pm
8-K
anhubth0xsoakur
5 Oct 23
Entry into a Material Definitive Agreement
5:03pm
8-K
0qec4lubv2aybgwxsibu
14 Aug 23
Jaguar Health Reports Second Quarter 2023 Financial Results
9:05am
8-K
4leox3b gsi0
7 Jul 23
Jaguar Health Reports Approval of All Proposals at 2023 Annual Meeting of Stockholders
5:27pm
8-K
ipt6di2
3 Jul 23
Entry into a Material Definitive Agreement
5:00pm
8-K
en2b ijuuy
19 May 23
Departure of Directors or Certain Officers
5:00pm
8-K
2a7gqhnx2vfzne
15 May 23
Jaguar Health Reports First Quarter 2023 Financial Results
8:33am
8-K
i26w2s5j 7rx
12 May 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
8-K
8hmzfcrku481747z4m
9 May 23
Jaguar Completes Enrollment in its Pivotal Phase 3 OnTarget Trial of Crofelemer for Prophylaxis of Cancer Therapy-Related Diarrhea
8:30am
8-K
b5j1v 0mibr3dne
27 Mar 23
Jaguar Health Reports 2022 Financial Results – Prescription Revenues up 179% to $11.9 Million
7:01am
8-K
ltij0e
8 Feb 23
Other Events
8:45am
8-K
n4syhyy759bphcxa 1hk
6 Feb 23
Entry into a Material Definitive Agreement
5:01pm
8-K
ilabg8jt7bjpvhzamd
20 Jan 23
Jaguar Health Reports Voting Results from January 2023 Special Meeting of Stockholders
6:13pm
8-K
dyahavkp5v9z3h ybdk
6 Jan 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:16pm